Status:
RECRUITING
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
Lead Sponsor:
Bradley Hospital
Conditions:
Suicide Ideation
Suicidal Behaviors
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
This study will test a model of providing treatment to Latinx/Hispanic youth, who experience suicidal thoughts and behavior, and their caregivers. An affirmative and culturally relevant treatment will...
Detailed Description
The objective of this proposal is to test a New Clinical Model to engage Latinx/Hispanic (L/H) youth and their caregivers in a culturally centered, evidence-based treatment for suicidal behaviors (SB)...
Eligibility Criteria
Inclusion
- Latinx, defined as have been born in a Latin country or having at least one biological parent, grandparent or an ancestor that was born in a Latin country
- Severe Suicidal Ideation (SI), defined as one of the following:
- SIQ-JR \> 22 or endorsing any critical items (2, 3, 4, 7, 8, 9) with at least "about 1x/month"
- CDI-II \> 15 and endorsing "I think about killing myself but would not do it" OR "I think about killing myself."
- PHQ-9 \> 10 \& endorsing the item "Thoughts that you would be better off dead, or of hurting yourself in some way" with a frequency of "several days" or greater or endorsing the item "Has there been a time in the past month when you have had serious thoughts about ending your life?
- Suicidal crisis within the past 12 months
- Caregivers and adolescents fluent in Spanish or English language and legal guardian willing to participate
Exclusion
- Participants will be referred to a different treatment program if their main clinical complaint is any of the following:
- Behavioral (e.g., conduct disorder, or substance use disorder)
- An eating disorder
- Obsessive-compulsive disorder
- A developmental issue (e.g., speech, occupational, families looking for assessments, treatment for autism) or a significant cognitive delay that may require specialized treatment adjustments.
Key Trial Info
Start Date :
March 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06882798
Start Date
March 28 2024
End Date
January 1 2027
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bradley Hasbro Children's Research Center
Providence, Rhode Island, United States, 02903